Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
- PMID: 30705156
- PMCID: PMC6613350
- DOI: 10.1126/science.aau8959
Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
Erratum in
-
Erratum for the Research Article "Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition" by E. Ballinger, J. Mosior, T. Hartman, K. Burns-Huang, B. Gold, R. Morris, L. Goullieux, I. Blanc, J. Vaubourgeix, S. Lagrange, L. Fraisse, S. Sans, C. Couturier, E. Bacqué, K. Rhee, S. M. Scarry, J. Aubé, G. Yang, O. Ouerfelli, D. Schnappinger, T. R. Ioerger, C. A. Engelhart, J. A. McConnell, K. McAulay, A. Fay, C. Roubert, J. Sacchettini, C. Nathan.Science. 2019 Jun 21;364(6446):eaay3546. doi: 10.1126/science.aay3546. Science. 2019. PMID: 31221826 No abstract available.
Abstract
Mycobacterium tuberculosis (Mtb) is the leading infectious cause of death in humans. Synthesis of lipids critical for Mtb's cell wall and virulence depends on phosphopantetheinyl transferase (PptT), an enzyme that transfers 4'-phosphopantetheine (Ppt) from coenzyme A (CoA) to diverse acyl carrier proteins. We identified a compound that kills Mtb by binding and partially inhibiting PptT. Killing of Mtb by the compound is potentiated by another enzyme encoded in the same operon, Ppt hydrolase (PptH), that undoes the PptT reaction. Thus, loss-of-function mutants of PptH displayed antimicrobial resistance. Our PptT-inhibitor cocrystal structure may aid further development of antimycobacterial agents against this long-sought target. The opposing reactions of PptT and PptH uncover a regulatory pathway in CoA physiology.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures





Comment in
-
Expanding the anti-TB arsenal.Science. 2019 Feb 1;363(6426):457-458. doi: 10.1126/science.aaw5224. Science. 2019. PMID: 30705174 No abstract available.
Similar articles
-
Characterization of Phosphopantetheinyl Hydrolase from Mycobacterium tuberculosis.Microbiol Spectr. 2021 Oct 31;9(2):e0092821. doi: 10.1128/Spectrum.00928-21. Epub 2021 Sep 22. Microbiol Spectr. 2021. PMID: 34550010 Free PMC article.
-
Structural insights into phosphopantetheinyl hydrolase PptH from Mycobacterium tuberculosis.Protein Sci. 2020 Mar;29(3):744-757. doi: 10.1002/pro.3813. Epub 2020 Jan 20. Protein Sci. 2020. PMID: 31886928 Free PMC article.
-
4'-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo.PLoS Pathog. 2012 Dec;8(12):e1003097. doi: 10.1371/journal.ppat.1003097. Epub 2012 Dec 20. PLoS Pathog. 2012. PMID: 23308068 Free PMC article.
-
The α/β Hydrolase Fold Proteins of Mycobacterium tuberculosis, with Reference to their Contribution to Virulence.Curr Protein Pept Sci. 2017;18(3):190-210. doi: 10.2174/1389203717666160729093515. Curr Protein Pept Sci. 2017. PMID: 27480283 Review.
-
Deciphering the role of VapBC toxin-antitoxin systems in Mycobacterium tuberculosis stress adaptation.Future Microbiol. 2024;19(18):1587-1599. doi: 10.1080/17460913.2024.2412447. Epub 2024 Oct 21. Future Microbiol. 2024. PMID: 39431307 Review.
Cited by
-
Using tea nanoclusters as β-lactamase inhibitors to cure multidrug-resistant bacterial pneumonia: A promising therapeutic strategy by Chinese materioherbology.Fundam Res. 2021 Nov 25;2(3):496-504. doi: 10.1016/j.fmre.2021.11.019. eCollection 2022 May. Fundam Res. 2021. PMID: 38933406 Free PMC article.
-
Characterization of Phosphopantetheinyl Hydrolase from Mycobacterium tuberculosis.Microbiol Spectr. 2021 Oct 31;9(2):e0092821. doi: 10.1128/Spectrum.00928-21. Epub 2021 Sep 22. Microbiol Spectr. 2021. PMID: 34550010 Free PMC article.
-
Targeting Siderophore Biosynthesis to Thwart Microbial Growth.Int J Mol Sci. 2025 Apr 11;26(8):3611. doi: 10.3390/ijms26083611. Int J Mol Sci. 2025. PMID: 40332123 Free PMC article. Review.
-
Biology of antimicrobial resistance and approaches to combat it.Sci Transl Med. 2020 Jun 24;12(549):eaaz6992. doi: 10.1126/scitranslmed.aaz6992. Sci Transl Med. 2020. PMID: 32581135 Free PMC article. Review.
-
Drug-resistance in Mycobacterium tuberculosis: where we stand.Medchemcomm. 2019 Jun 11;10(8):1342-1360. doi: 10.1039/c9md00057g. eCollection 2019 Aug 1. Medchemcomm. 2019. PMID: 31534654 Free PMC article. Review.
References
-
- Walsh C, Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775–781 (2000). - PubMed
-
- Moolman WJ, de Villiers M, Strauss E, Recent advances in targeting coenzyme A biosynthesis and utilization for antimicrobial drug development. Biochem Soc Trans 42, 1080–1086 (2014). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources